Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.79 and traded as high as $2.99. Evotec shares last traded at $2.99, with a volume of 24,629 shares traded.
Evotec Stock Up 1.3%
The business’s fifty day simple moving average is $2.79 and its 200 day simple moving average is $3.14. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The stock has a market cap of $1.00 billion, a price-to-earnings ratio of 7.39 and a beta of 0.98.
About Evotec
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Featured Articles
- Five stocks we like better than Evotec
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
